Indications
Therapeutic Asset Ratings
18,140 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Muamycin
Peritoneal Carcinomatosis
H. Lee Moffitt Cancer Center and Research Institute
P4
B
(62)
Nepenthe
Breast Cancer
Antalya Training and Research Hospital
P4
B
(62)
Neurotop
Neuralgia
Karbala University
P4
B
(62)
Ondansetron
Chronic Pain Syndrome
Tianjin Medical University General Hospital
P4
B
(62)
Ondansetron
Morbid Obesity
Tanta University
P4
B
(62)
Oxygen
Anxiety Disorder
Beth Israel Deaconess Medical Center
P4
B
(62)
Oxygen
Prostate Disorder
Beth Israel Deaconess Medical Center
P4
B
(62)
Oxygen
Major Depressive Disorder
Women's College Hospital
P4
B
(62)
Pazopanib
Breast Carcinoma
University Medical Center Groningen
P4
B
(62)
PBR28
Multiple Sclerosis
Massachusetts General Hospital
P4
B
(62)
Pravastatin
Cardiovascular Disorder
McMaster University
P4
B
(62)
Pregabalin
Post-Operative Pain, Non-Human Animal
Medical University of Warsaw
P4
B
(62)
Propofol
Depressive Disorder
Min Su
P4
B
(62)
Propofol
Parkinson Disease
Nyree Penn
P4
B
(62)
Rifaximin
Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai Changzheng Hospital
P4
B
(62)
Rifaximin
Portal Hypertension
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
P4
B
(62)
Ropivacaine
Chronic Pain Syndrome
Biobizkaia Health Research Institute
P4
B
(62)
Sevoflurane
Chronic Pain Syndrome
Nantes University Hospital
P4
B
(62)
Simvastatin
Transient Ischemic Attack
Prof. dr. Nathalie van der Velde
P4
B
(62)
Sirolimus
Skin Squamous Cell Carcinoma
Dana-Farber Cancer Institute
P4
B
(62)
Sitagliptin
Metabolic Dysfunction-Associated Steatotic Liver Disease
University Health Network, Toronto
P4
B
(62)
Sufentanyl
Scoliosis
Peking University First Hospital
P4
B
(62)
Tapentadol
Chronic Pain Syndrome
University of Thessaly
P4
B
(62)
Tapentadol
Neuralgia
Aretaieion University Hospital
P4
B
(62)
Temsirolimus
Non-Hodgkin Lymphoma
Canadian Cancer Trials Group
P4
B
(62)
Showing 3101 to 3125 of 18,140 assets
Previous
Page 125 of 726
Next